Covered recipient · General Payments record
LINGAIAH JANUMPALLY
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$6,473.05
- Reported across 323 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,993.38 | 82 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $296.44 | 8 |
| SK Life Science, Inc. | $185.42 | 10 |
| EISAI INC. | $148.93 | 7 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $120.23 | 6 |
| ANI Pharmaceuticals, Inc. | $116.97 | 5 |
| ARGENX US, INC. | $115.06 | 4 |
| CSL Behring | $101.82 | 3 |
| Biogen, Inc. | $78.57 | 3 |
| Genentech USA, Inc. | $76.65 | 3 |
| Lilly USA, LLC | $72.29 | 3 |
| ABBVIE INC. | $67.81 | 3 |
| Lundbeck LLC | $58.03 | 3 |
| Neurelis, Inc. | $55.48 | 2 |
| Octapharma USA, Inc. | $55.37 | 2 |
| TG THERAPEUTICS, INC. | $51.26 | 2 |
| Alnylam Pharmaceuticals Inc. | $47.45 | 2 |
| Alexion Pharmaceuticals, Inc. | $47.43 | 2 |
| Amgen Inc. | $47.22 | 2 |
| Otsuka America Pharmaceutical, Inc. | $45.22 | 2 |
| Neurocrine BioSciences, Inc. | $32.71 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $22.34 | 1 |
| LivaNova USA, Inc. | $21.80 | 1 |
| Grifols USA, LLC | $21.60 | 1 |
| Mallinckrodt Hospital Products Inc. | $19.84 | 1 |
| Sandoz Inc. | $19.35 | 1 |
| PFIZER INC. | $18.82 | 1 |
| Abbott Laboratories | $17.70 | 1 |
| Microtransponder, Inc. | $17.29 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (82)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.